OrphanDrug
OrphanDrug
Pharma Knowledge Base

Charlevoix-Saguenay spastic ataxia

ICD-10: G11.1MeSH: C536787ORPHA: 98757

Contents

  1. 1. Overview
  2. 2. Available Treatments
  3. 3. Clinical Presentation
  4. 4. Classification & Codes

Overview

neurological disease

Available Treatments (0)

No treatments linked yet

Clinical trials or compassionate use may be available — consult a specialist.

Clinical Presentation

Signs and symptoms associated with Charlevoix-Saguenay spastic ataxia, sourced from HPO and Orphanet clinical annotations.

ProptosisProgressive external ophthalmoplegiaNystagmusDiplopiaDelayed speech and language developmentDysarthriaDystoniaHyperreflexiaAbnormality of extrapyramidal motor functionProgressive cerebellar ataxiaClumsinessSkeletal muscle atrophyAbnormal pyramidal signVocal cord paralysisAbnormal vestibular functionAbnormality of temperature regulation

Classification & Codes

ICD-10 Code

G11.1

MeSH Code

C536787

Orphanet Code

ORPHA:98757
Charlevoix-Saguenay spastic ataxia
ICD-10G11.1
MeSHC536787
OrphanetORPHA:98757
Treatments0 drug(s)
Symptoms on record16 signs
Statuspublished
Factual Authority
Last Updated3/20/2026
Clinical DataHPO · Orphanet
Drug DataFDA · EMA · CDSCO